Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcturus Therapeutics Holdings (ARCT) Other Non-Current Assets: 2018-2025

Historic Other Non-Current Assets for Arcturus Therapeutics Holdings (ARCT) over the last 8 years, with Sep 2025 value amounting to $1.9 million.

  • Arcturus Therapeutics Holdings' Other Non-Current Assets changed negligibly% to $1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.9 million, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $1.9 million for FY2024, which is 96.57% down from last year.
  • As of Q3 2025, Arcturus Therapeutics Holdings' Other Non-Current Assets stood at $1.9 million, which was down 0.00% from $1.9 million recorded in Q2 2025.
  • Over the past 5 years, Arcturus Therapeutics Holdings' Other Non-Current Assets peaked at $55.0 million during Q4 2023, and registered a low of $107,000 during Q1 2021.
  • Moreover, its 3-year median value for Other Non-Current Assets was $1.9 million (2025), whereas its average is $10.1 million.
  • In the last 5 years, Arcturus Therapeutics Holdings' Other Non-Current Assets soared by 2,526.55% in 2023 and then slumped by 96.57% in 2024.
  • Quarterly analysis of 5 years shows Arcturus Therapeutics Holdings' Other Non-Current Assets stood at $2.1 million in 2021, then grew by 0.82% to $2.1 million in 2022, then skyrocketed by 2,526.55% to $55.0 million in 2023, then tumbled by 96.57% to $1.9 million in 2024, then remained steady at $1.9 million in 2025.
  • Its Other Non-Current Assets stands at $1.9 million for Q3 2025, versus $1.9 million for Q2 2025 and $18.4 million for Q1 2025.